In contrast, a majority 19/28 (68%) of RYR1-RM affected individuals exhibited systemic NAD+ deficiency (< 21 μM) and 2/28 (7%) had increased NADH concentrations (> 1.6 μM). The gene discussed is RYR1; the disease is hyperinsulinemic hypoglycemia, familial, 4.